Literature DB >> 659863

Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytes.

J C Guckian, W D Christensen, D P Fine.   

Abstract

Trypan blue completely inhibited attachment of human polymorphonuclear leukocytes (PMN) to Sepharose beads coated with C3 ant to sheep erythrocytes coated with IgM plus C3, but it did not inhibit attachment to erythrocytes coated with IgG. These results suggested that trypan blue inhibited C-mediated attachment to PMN membranes. Corroborative studies were performed with a strain of Staphylococcus aureus that requires C but not antibody, for opsonization and that activates the alternative pathway. Trypan blue was not toxic to PMN or bacteria, did nto interfere with immunoglobulin or C interactions, and did not affect attachment of opsonins to bacteria. However, the dye impaired PMN killing of S. aureus in normal nonimmune serum by inhibiting bacterial attachment to and ingestion by PMN. Further evidence that the inhibition was at the C3 receptor level came from the observations that, 1) once staphylococci were attached to PMN at either 37 degrees C or 0 degrees C, addition of trypan blue did not inhibit killing; and 2) trypan blue inhibited killing of bacteria opsonized with serum sufficient in C but previously absorbed at 0 degrees C with the same strain of organism to deplete specific antibody. Further studies with this agent may elucidate the roles of opsonic receptors on human phagocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659863

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  In vitro killing of erythromycin-exposed group A streptococci by polymorphonuclear leukocytes.

Authors:  H Pruul; B Wetherall; P McDonald
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Antibody-mediated bacterial adhesion to cytomegalovirus-induced Fc receptors. Potential relationship to secondary infections complicating herpesvirus infections.

Authors:  P A Mackowiak; M Marling-Cason; J W Smith; J P Luby
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

3.  Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.

Authors:  J Fierer; F Finley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

4.  The characterization of trypan blue-induced tumors in Wistar rats.

Authors:  R J Ford; F F Becker
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

5.  Defective phagocytosis confined to Staphylococcus aureus in a female infant with recurrent infections.

Authors:  S Ito; H Mikawa; T Hirao; T Yoshida; R Okuda
Journal:  Eur J Pediatr       Date:  1980       Impact factor: 3.183

6.  Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes.

Authors:  J I Ravdin; R L Guerrant
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

7.  Trypan blue inhibition of complement receptor function on various cells.

Authors:  B L Harper; D P Fine; J C Guckian; T Cavallo
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

8.  Complement-independent adherence of Escherichia coli to complement receptors in vitro.

Authors:  D P Fine; B L Harper; E D Carpenter; C P Davis; T Cavallo; J C Guckian
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol.

Authors:  H Pruul; B L Wetherall; P J McDonald
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

10.  Complement does not play a role in promoting Babesia rodhaini infections in Balb/C mice.

Authors:  W Seinen; T Stegmann; H Kuil
Journal:  Z Parasitenkd       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.